DCM
ABBV icon

Driehaus Capital Management’s AbbVie ABBV Stock Holding History

Driehaus Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,039
Closed -$443K – 355
2026
Q1 		$443K Buy
+2,039
New +$452K ﹤0.01% 347
2025
Q1 		– Sell
-3,051
Closed -$542K – 397
2024
Q4 		$542K Buy
+3,051
New +$561K ﹤0.01% 351
2024
Q2 		– Sell
-1,376
Closed -$251K – 362
2024
Q1 		$251K Buy
+1,376
New +$237K ﹤0.01% 370
2022
Q3 		– Sell
-1,836
Closed -$281K – 344
2022
Q2 		$281K Buy
+1,836
New +$281K ﹤0.01% 327
2021
Q4 		– Sell
-2,770
Closed -$299K – 365
2021
Q3 		$299K Buy
+2,770
New +$317K ﹤0.01% 357
2020
Q4 		– Sell
-3,584
Closed -$314K – 413
2020
Q3 		$314K Buy
3,584
+947
+36% +$89.2K 0.01% 361
2020
Q2 		$259K Sell
2,637
-31
-1% -$2.73K 0.01% 350
2020
Q1 		$203K Buy
+2,668
New +$227K 0.01% 386
2018
Q3 		– Sell
-2,344
Closed -$217K – 451
2018
Q2 		$217K Sell
2,344
-154
-6% -$15K 0.01% 445
2018
Q1 		$236K Sell
2,498
-331
-12% -$36.4K 0.01% 461
2017
Q4 		$274K Hold
2,829
– – 0.01% 476
2017
Q3 		$251K Buy
+2,829
New +$215K 0.01% 447
2015
Q1 		– Sell
-10,618
Closed -$695K – 490
2014
Q4 		$695K Sell
10,618
-40,726
-79% -$2.57M 0.03% 414
2014
Q3 		$2.97M Buy
51,344
+37,068
+260% +$2.06M 0.11% 240
2014
Q2 		$806K Buy
14,276
+572
+4% +$30K 0.03% 466
2014
Q1 		$704K Buy
+13,704
New +$693K 0.02% 429

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Driehaus Capital Management's ABBV Position: Q2 2026 in Review

Driehaus Capital Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 2,039 shares — an estimated $443K sold.

Driehaus Capital Management first reported a position in ABBV in Q1 2014 and held it in 16 quarters. The position peaked at $2.97M in Q3 2014. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Driehaus Capital Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Driehaus Capital Management sold 2,039 AbbVie shares in Q2 2026, an estimated $443K.
  • Driehaus Capital Management first reported a position in AbbVie in Q1 2014 and held it in 16 quarters.
  • Driehaus Capital Management's AbbVie position peaked at $2.97M in Q3 2014.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.